[{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F359V","name":"F359V","refResidues":"F","proteinStart":359,"proteinEnd":359,"variantResidues":"V","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Nilotinib"],"drugPmids":["16775235","19589924","19652056","17785585","23502220"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F359I","name":"F359I","refResidues":"F","proteinStart":359,"proteinEnd":359,"variantResidues":"I","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Nilotinib"],"drugPmids":["16775235","19589924","19652056","17785585","23502220"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F317I","name":"F317I","refResidues":"F","proteinStart":317,"proteinEnd":317,"variantResidues":"I","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Dasatinib"],"drugPmids":["19589924","19779040","17710227","17339191","17785585","17114651"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"Y253H","name":"Y253H","refResidues":"Y","proteinStart":253,"proteinEnd":253,"variantResidues":"H","referenceGenomes":["GRCh38","GRCh37"]},"level":"2","drug":["Dasatinib"],"drugPmids":["15930265","19779040","19075254"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F359I","name":"F359I","refResidues":"F","proteinStart":359,"proteinEnd":359,"variantResidues":"I","referenceGenomes":["GRCh38","GRCh37"]},"level":"2","drug":["Dasatinib"],"drugPmids":["17496201"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"NA","isGenerallyTruncating":false,"description":"NA"},"alteration":"BCR-ABL1 Fusion","name":"BCR-ABL1 Fusion","refResidues":null,"proteinStart":-1,"proteinEnd":100000,"variantResidues":null,"referenceGenomes":["GRCh38","GRCh37"]},"level":"2","drug":["Bosutinib"],"drugPmids":["21865346","24345751","22371878","25132497","19075254","26040495"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F359V","name":"F359V","refResidues":"F","proteinStart":359,"proteinEnd":359,"variantResidues":"V","referenceGenomes":["GRCh38","GRCh37"]},"level":"2","drug":["Dasatinib"],"drugPmids":["17496201"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F359V","name":"F359V","refResidues":"F","proteinStart":359,"proteinEnd":359,"variantResidues":"V","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Nilotinib"],"drugPmids":["16775235","19589924","19652056","17785585","23502220"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"E255K","name":"E255K","refResidues":"E","proteinStart":255,"proteinEnd":255,"variantResidues":"K","referenceGenomes":["GRCh38","GRCh37"]},"level":"2","drug":["Dasatinib"],"drugPmids":["15930265","19779040","19075254"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"T315A","name":"T315A","refResidues":"T","proteinStart":315,"proteinEnd":315,"variantResidues":"A","referenceGenomes":["GRCh38","GRCh37"]},"level":"2","drug":["Bosutinib"],"drugPmids":["15930265","19075254"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"V299L","name":"V299L","refResidues":"V","proteinStart":299,"proteinEnd":299,"variantResidues":"L","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Imatinib"],"drugPmids":["17405907","17189410","11861307"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"T315A","name":"T315A","refResidues":"T","proteinStart":315,"proteinEnd":315,"variantResidues":"A","referenceGenomes":["GRCh38","GRCh37"]},"level":"2","drug":["Nilotinib"],"drugPmids":["15930265","23086624","19075254"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"T315A","name":"T315A","refResidues":"T","proteinStart":315,"proteinEnd":315,"variantResidues":"A","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Imatinib"],"drugPmids":["19925053","20010464","12623848","17189410","17785585"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F359V","name":"F359V","refResidues":"F","proteinStart":359,"proteinEnd":359,"variantResidues":"V","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Imatinib"],"drugPmids":["19925053","20010464","12623848","17189410","17785585"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F359I","name":"F359I","refResidues":"F","proteinStart":359,"proteinEnd":359,"variantResidues":"I","referenceGenomes":["GRCh38","GRCh37"]},"level":"2","drug":["Bosutinib"],"drugPmids":["15930265","19075254"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F317I","name":"F317I","refResidues":"F","proteinStart":317,"proteinEnd":317,"variantResidues":"I","referenceGenomes":["GRCh38","GRCh37"]},"level":"2","drug":["Nilotinib"],"drugPmids":["15930265","23086624","19075254"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"NA","isGenerallyTruncating":false,"description":"NA"},"alteration":"BCR-ABL1 Fusion","name":"BCR-ABL1 Fusion","refResidues":null,"proteinStart":-1,"proteinEnd":100000,"variantResidues":null,"referenceGenomes":["GRCh38","GRCh37"]},"level":"1","drug":["Ponatinib"],"drugPmids":["24180494"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"Y253H","name":"Y253H","refResidues":"Y","proteinStart":253,"proteinEnd":253,"variantResidues":"H","referenceGenomes":["GRCh38","GRCh37"]},"level":"2","drug":["Bosutinib"],"drugPmids":["15930265","19075254"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"NA","isGenerallyTruncating":false,"description":"NA"},"alteration":"BCR-ABL1 Fusion","name":"BCR-ABL1 Fusion","refResidues":null,"proteinStart":-1,"proteinEnd":100000,"variantResidues":null,"referenceGenomes":["GRCh38","GRCh37"]},"level":"3A","drug":["Asciminib"],"drugPmids":["31826340"],"drugAbstracts":[{"link":"http://abstracts.asco.org/214/AbstView_214_220317.html","abstract":"Mauro, M. et al. Abstract# TPS7081, ASCO 2018"}]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F317C","name":"F317C","refResidues":"F","proteinStart":317,"proteinEnd":317,"variantResidues":"C","referenceGenomes":["GRCh38","GRCh37"]},"level":"2","drug":["Nilotinib"],"drugPmids":["15930265","23086624","19075254"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F317C","name":"F317C","refResidues":"F","proteinStart":317,"proteinEnd":317,"variantResidues":"C","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Imatinib"],"drugPmids":["19925053","20010464","12623848","17189410","17785585"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F317I","name":"F317I","refResidues":"F","proteinStart":317,"proteinEnd":317,"variantResidues":"I","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Imatinib"],"drugPmids":["19925053","20010464","12623848","17189410","17785585"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"NA","isGenerallyTruncating":false,"description":"NA"},"alteration":"BCR-ABL1 Fusion","name":"BCR-ABL1 Fusion","refResidues":null,"proteinStart":-1,"proteinEnd":100000,"variantResidues":null,"referenceGenomes":["GRCh38","GRCh37"]},"level":"1","drug":["Nilotinib"],"drugPmids":["28218239","20525993","23502220"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"E255K","name":"E255K","refResidues":"E","proteinStart":255,"proteinEnd":255,"variantResidues":"K","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Nilotinib"],"drugPmids":["16775235","19589924","19652056","17785585","23502220"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F317L","name":"F317L","refResidues":"F","proteinStart":317,"proteinEnd":317,"variantResidues":"L","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Bosutinib"],"drugPmids":["26040495"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F359C","name":"F359C","refResidues":"F","proteinStart":359,"proteinEnd":359,"variantResidues":"C","referenceGenomes":["GRCh38","GRCh37"]},"level":"2","drug":["Bosutinib"],"drugPmids":["19075254","26040495"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F317I","name":"F317I","refResidues":"F","proteinStart":317,"proteinEnd":317,"variantResidues":"I","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Dasatinib"],"drugPmids":["17496201","17339191","20131302"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F317V","name":"F317V","refResidues":"F","proteinStart":317,"proteinEnd":317,"variantResidues":"V","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Imatinib"],"drugPmids":["17405907","17189410","11861307"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F359C","name":"F359C","refResidues":"F","proteinStart":359,"proteinEnd":359,"variantResidues":"C","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Nilotinib"],"drugPmids":["16775235","19589924","19652056","17785585","23502220"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"V299L","name":"V299L","refResidues":"V","proteinStart":299,"proteinEnd":299,"variantResidues":"L","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Bosutinib"],"drugPmids":["26040495"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"E255K","name":"E255K","refResidues":"E","proteinStart":255,"proteinEnd":255,"variantResidues":"K","referenceGenomes":["GRCh38","GRCh37"]},"level":"2","drug":["Bosutinib"],"drugPmids":["15930265","19075254"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F317C","name":"F317C","refResidues":"F","proteinStart":317,"proteinEnd":317,"variantResidues":"C","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Imatinib"],"drugPmids":["17405907","17189410","11861307"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F317L","name":"F317L","refResidues":"F","proteinStart":317,"proteinEnd":317,"variantResidues":"L","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Bosutinib"],"drugPmids":["21865346","22371878"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":184,"subtype":"AML with BCR-ABL1","code":"AMLBCRABL1","color":"LightSalmon","mainType":"Leukemia","level":5,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"NA","isGenerallyTruncating":false,"description":"NA"},"alteration":"BCR-ABL1 Fusion","name":"BCR-ABL1 Fusion","refResidues":null,"proteinStart":-1,"proteinEnd":100000,"variantResidues":null,"referenceGenomes":["GRCh38","GRCh37"]},"level":"Dx1","drug":[],"drugPmids":["27297971"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F317I","name":"F317I","refResidues":"F","proteinStart":317,"proteinEnd":317,"variantResidues":"I","referenceGenomes":["GRCh38","GRCh37"]},"level":"2","drug":["Bosutinib"],"drugPmids":["19075254","26040495"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"NA","isGenerallyTruncating":false,"description":"NA"},"alteration":"BCR-ABL1 Fusion","name":"BCR-ABL1 Fusion","refResidues":null,"proteinStart":-1,"proteinEnd":100000,"variantResidues":null,"referenceGenomes":["GRCh38","GRCh37"]},"level":"1","drug":["Bosutinib"],"drugPmids":["29091516","24345751","26040495"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F317V","name":"F317V","refResidues":"F","proteinStart":317,"proteinEnd":317,"variantResidues":"V","referenceGenomes":["GRCh38","GRCh37"]},"level":"2","drug":["Bosutinib"],"drugPmids":["19075254","26040495"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"E255V","name":"E255V","refResidues":"E","proteinStart":255,"proteinEnd":255,"variantResidues":"V","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Imatinib"],"drugPmids":["19925053","20010464","12623848","17189410","17785585"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F317L","name":"F317L","refResidues":"F","proteinStart":317,"proteinEnd":317,"variantResidues":"L","referenceGenomes":["GRCh38","GRCh37"]},"level":"2","drug":["Nilotinib"],"drugPmids":["15930265","23086624","19075254"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F317L","name":"F317L","refResidues":"F","proteinStart":317,"proteinEnd":317,"variantResidues":"L","referenceGenomes":["GRCh38","GRCh37"]},"level":"2","drug":["Nilotinib"],"drugPmids":["15930265","23086624","19075254"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"E255V","name":"E255V","refResidues":"E","proteinStart":255,"proteinEnd":255,"variantResidues":"V","referenceGenomes":["GRCh38","GRCh37"]},"level":"2","drug":["Bosutinib"],"drugPmids":["19075254","26040495"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"T315A","name":"T315A","refResidues":"T","proteinStart":315,"proteinEnd":315,"variantResidues":"A","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Dasatinib"],"drugPmids":["19589924","19779040","17710227","17339191","17785585","17114651"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F359C","name":"F359C","refResidues":"F","proteinStart":359,"proteinEnd":359,"variantResidues":"C","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Imatinib"],"drugPmids":["19925053","20010464","12623848","17189410","17785585"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"T315I","name":"T315I","refResidues":"T","proteinStart":315,"proteinEnd":315,"variantResidues":"I","referenceGenomes":["GRCh38","GRCh37"]},"level":"1","drug":["Ponatinib"],"drugPmids":["24180494","23190221","19878872"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F317I","name":"F317I","refResidues":"F","proteinStart":317,"proteinEnd":317,"variantResidues":"I","referenceGenomes":["GRCh38","GRCh37"]},"level":"2","drug":["Nilotinib"],"drugPmids":["15930265","23086624","19075254"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"V299L","name":"V299L","refResidues":"V","proteinStart":299,"proteinEnd":299,"variantResidues":"L","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Imatinib"],"drugPmids":["19925053","20010464","12623848","17189410","17785585"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F317L","name":"F317L","refResidues":"F","proteinStart":317,"proteinEnd":317,"variantResidues":"L","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Imatinib"],"drugPmids":["17405907","17189410","11861307"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F359I","name":"F359I","refResidues":"F","proteinStart":359,"proteinEnd":359,"variantResidues":"I","referenceGenomes":["GRCh38","GRCh37"]},"level":"2","drug":["Dasatinib"],"drugPmids":["15930265","19779040","19075254"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"Y253H","name":"Y253H","refResidues":"Y","proteinStart":253,"proteinEnd":253,"variantResidues":"H","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Imatinib"],"drugPmids":["19925053","20010464","12623848","17189410","17785585"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F317V","name":"F317V","refResidues":"F","proteinStart":317,"proteinEnd":317,"variantResidues":"V","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Dasatinib"],"drugPmids":["17496201","17339191","20131302"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"G250E","name":"G250E","refResidues":"G","proteinStart":250,"proteinEnd":250,"variantResidues":"E","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Imatinib"],"drugPmids":["19925053","20010464","12623848","17189410","17785585"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F317V","name":"F317V","refResidues":"F","proteinStart":317,"proteinEnd":317,"variantResidues":"V","referenceGenomes":["GRCh38","GRCh37"]},"level":"2","drug":["Nilotinib"],"drugPmids":["15930265","23086624","19075254"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"E255K","name":"E255K","refResidues":"E","proteinStart":255,"proteinEnd":255,"variantResidues":"K","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Imatinib"],"drugPmids":["17405907","17189410","11861307"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"T315I","name":"T315I","refResidues":"T","proteinStart":315,"proteinEnd":315,"variantResidues":"I","referenceGenomes":["GRCh38","GRCh37"]},"level":"1","drug":["Ponatinib"],"drugPmids":["24180494","23190221","29567798"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F317I","name":"F317I","refResidues":"F","proteinStart":317,"proteinEnd":317,"variantResidues":"I","referenceGenomes":["GRCh38","GRCh37"]},"level":"2","drug":["Bosutinib"],"drugPmids":["15930265","19075254"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F317C","name":"F317C","refResidues":"F","proteinStart":317,"proteinEnd":317,"variantResidues":"C","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Dasatinib"],"drugPmids":["17496201","17339191","20131302"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"E255K","name":"E255K","refResidues":"E","proteinStart":255,"proteinEnd":255,"variantResidues":"K","referenceGenomes":["GRCh38","GRCh37"]},"level":"2","drug":["Dasatinib"],"drugPmids":["17496201"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F317C","name":"F317C","refResidues":"F","proteinStart":317,"proteinEnd":317,"variantResidues":"C","referenceGenomes":["GRCh38","GRCh37"]},"level":"2","drug":["Bosutinib"],"drugPmids":["15930265","19075254"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"NA","isGenerallyTruncating":false,"description":"NA"},"alteration":"BCR-ABL1 Fusion","name":"BCR-ABL1 Fusion","refResidues":null,"proteinStart":-1,"proteinEnd":100000,"variantResidues":null,"referenceGenomes":["GRCh38","GRCh37"]},"level":"2","drug":["Nilotinib"],"drugPmids":["16775235","26065651"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F317V","name":"F317V","refResidues":"F","proteinStart":317,"proteinEnd":317,"variantResidues":"V","referenceGenomes":["GRCh38","GRCh37"]},"level":"2","drug":["Bosutinib"],"drugPmids":["15930265","19075254"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F317L","name":"F317L","refResidues":"F","proteinStart":317,"proteinEnd":317,"variantResidues":"L","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Dasatinib"],"drugPmids":["17496201","17339191","20131302"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":597,"subtype":"Chronic Myeloid Leukemia, BCR-ABL1+","code":"CMLBCRABL1","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":5,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"NA","isGenerallyTruncating":false,"description":"NA"},"alteration":"BCR-ABL1 Fusion","name":"BCR-ABL1 Fusion","refResidues":null,"proteinStart":-1,"proteinEnd":100000,"variantResidues":null,"referenceGenomes":["GRCh38","GRCh37"]},"level":"Dx1","drug":[],"drugPmids":["2989692"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"NA","isGenerallyTruncating":false,"description":"NA"},"alteration":"BCR-ABL1 Fusion","name":"BCR-ABL1 Fusion","refResidues":null,"proteinStart":-1,"proteinEnd":100000,"variantResidues":null,"referenceGenomes":["GRCh38","GRCh37"]},"level":"1","drug":["Dasatinib"],"drugPmids":["27217448","20525995"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F317C","name":"F317C","refResidues":"F","proteinStart":317,"proteinEnd":317,"variantResidues":"C","referenceGenomes":["GRCh38","GRCh37"]},"level":"2","drug":["Nilotinib"],"drugPmids":["15930265","23086624","19075254"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"E255K","name":"E255K","refResidues":"E","proteinStart":255,"proteinEnd":255,"variantResidues":"K","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Nilotinib"],"drugPmids":["16775235","19589924","19652056","17785585","23502220"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F359I","name":"F359I","refResidues":"F","proteinStart":359,"proteinEnd":359,"variantResidues":"I","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Nilotinib"],"drugPmids":["16775235","19589924","19652056","17785585","23502220"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"T315I","name":"T315I","refResidues":"T","proteinStart":315,"proteinEnd":315,"variantResidues":"I","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Nilotinib","Dasatinib","Imatinib","Bosutinib"],"drugPmids":["17339191","21562040","17768119","18403620","19075254"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":688,"subtype":"B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1 Like","code":"BLLBCRABL1L","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":5,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"NA","isGenerallyTruncating":false,"description":"NA"},"alteration":"Fusions","name":"Fusions","refResidues":null,"proteinStart":-1,"proteinEnd":100000,"variantResidues":null,"referenceGenomes":["GRCh38","GRCh37"]},"level":"Px1","drug":[],"drugPmids":["27870571"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F359V","name":"F359V","refResidues":"F","proteinStart":359,"proteinEnd":359,"variantResidues":"V","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Imatinib"],"drugPmids":["17405907","17189410","11861307"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"T315A","name":"T315A","refResidues":"T","proteinStart":315,"proteinEnd":315,"variantResidues":"A","referenceGenomes":["GRCh38","GRCh37"]},"level":"2","drug":["Bosutinib"],"drugPmids":["19075254","26040495"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"G250E","name":"G250E","refResidues":"G","proteinStart":250,"proteinEnd":250,"variantResidues":"E","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Bosutinib"],"drugPmids":["26040495"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F359I","name":"F359I","refResidues":"F","proteinStart":359,"proteinEnd":359,"variantResidues":"I","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Imatinib"],"drugPmids":["17405907","17189410","11861307"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"V299L","name":"V299L","refResidues":"V","proteinStart":299,"proteinEnd":299,"variantResidues":"L","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Dasatinib"],"drugPmids":["19589924","19779040","17710227","17339191","17785585","17114651"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":734,"subtype":"Acute Leukemias of Ambiguous Lineage","code":"ALAL","color":"LightSalmon","mainType":"Leukemia","level":3,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"NA","isGenerallyTruncating":false,"description":"NA"},"alteration":"BCR-ABL1 Fusion","name":"BCR-ABL1 Fusion","refResidues":null,"proteinStart":-1,"proteinEnd":100000,"variantResidues":null,"referenceGenomes":["GRCh38","GRCh37"]},"level":"Px1","drug":[],"drugPmids":["21228332","10457405"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"T315I","name":"T315I","refResidues":"T","proteinStart":315,"proteinEnd":315,"variantResidues":"I","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Nilotinib","Dasatinib","Imatinib","Bosutinib"],"drugPmids":["17339191","21562040","17768119","18403620","19075254"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F317V","name":"F317V","refResidues":"F","proteinStart":317,"proteinEnd":317,"variantResidues":"V","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Dasatinib"],"drugPmids":["19589924","19779040","17710227","17339191","17785585","17114651"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"Y253H","name":"Y253H","refResidues":"Y","proteinStart":253,"proteinEnd":253,"variantResidues":"H","referenceGenomes":["GRCh38","GRCh37"]},"level":"2","drug":["Bosutinib"],"drugPmids":["19075254","26040495"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":688,"subtype":"B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1 Like","code":"BLLBCRABL1L","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":5,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"NA","isGenerallyTruncating":false,"description":"NA"},"alteration":"Fusions","name":"Fusions","refResidues":null,"proteinStart":-1,"proteinEnd":100000,"variantResidues":null,"referenceGenomes":["GRCh38","GRCh37"]},"level":"Dx1","drug":[],"drugPmids":["27870571"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F317I","name":"F317I","refResidues":"F","proteinStart":317,"proteinEnd":317,"variantResidues":"I","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Imatinib"],"drugPmids":["17405907","17189410","11861307"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"E255K","name":"E255K","refResidues":"E","proteinStart":255,"proteinEnd":255,"variantResidues":"K","referenceGenomes":["GRCh38","GRCh37"]},"level":"2","drug":["Bosutinib"],"drugPmids":["19075254","26040495"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F317V","name":"F317V","refResidues":"F","proteinStart":317,"proteinEnd":317,"variantResidues":"V","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Imatinib"],"drugPmids":["19925053","20010464","12623848","17189410","17785585"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"E255V","name":"E255V","refResidues":"E","proteinStart":255,"proteinEnd":255,"variantResidues":"V","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Nilotinib"],"drugPmids":["16775235","19589924","19652056","17785585","23502220"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"NA","isGenerallyTruncating":false,"description":"NA"},"alteration":"BCR-ABL1 Fusion","name":"BCR-ABL1 Fusion","refResidues":null,"proteinStart":-1,"proteinEnd":100000,"variantResidues":null,"referenceGenomes":["GRCh38","GRCh37"]},"level":"Px1","drug":[],"drugPmids":["10749961"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F317V","name":"F317V","refResidues":"F","proteinStart":317,"proteinEnd":317,"variantResidues":"V","referenceGenomes":["GRCh38","GRCh37"]},"level":"2","drug":["Nilotinib"],"drugPmids":["15930265","23086624","19075254"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F359V","name":"F359V","refResidues":"F","proteinStart":359,"proteinEnd":359,"variantResidues":"V","referenceGenomes":["GRCh38","GRCh37"]},"level":"2","drug":["Bosutinib"],"drugPmids":["19075254","26040495"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F317C","name":"F317C","refResidues":"F","proteinStart":317,"proteinEnd":317,"variantResidues":"C","referenceGenomes":["GRCh38","GRCh37"]},"level":"2","drug":["Bosutinib"],"drugPmids":["19075254","26040495"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"NA","isGenerallyTruncating":false,"description":"NA"},"alteration":"BCR-ABL1 Fusion","name":"BCR-ABL1 Fusion","refResidues":null,"proteinStart":-1,"proteinEnd":100000,"variantResidues":null,"referenceGenomes":["GRCh38","GRCh37"]},"level":"1","drug":["Imatinib"],"drugPmids":["11287973","24441288","12200353"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"E255V","name":"E255V","refResidues":"E","proteinStart":255,"proteinEnd":255,"variantResidues":"V","referenceGenomes":["GRCh38","GRCh37"]},"level":"2","drug":["Bosutinib"],"drugPmids":["15930265","19075254"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"E255V","name":"E255V","refResidues":"E","proteinStart":255,"proteinEnd":255,"variantResidues":"V","referenceGenomes":["GRCh38","GRCh37"]},"level":"2","drug":["Dasatinib"],"drugPmids":["15930265","19779040","19075254"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"Y253H","name":"Y253H","refResidues":"Y","proteinStart":253,"proteinEnd":253,"variantResidues":"H","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Nilotinib"],"drugPmids":["16775235","19589924","19652056","17785585","23502220"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F317C","name":"F317C","refResidues":"F","proteinStart":317,"proteinEnd":317,"variantResidues":"C","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Dasatinib"],"drugPmids":["19589924","19779040","17710227","17339191","17785585","17114651"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F359I","name":"F359I","refResidues":"F","proteinStart":359,"proteinEnd":359,"variantResidues":"I","referenceGenomes":["GRCh38","GRCh37"]},"level":"2","drug":["Bosutinib"],"drugPmids":["19075254","26040495"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F317L","name":"F317L","refResidues":"F","proteinStart":317,"proteinEnd":317,"variantResidues":"L","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Dasatinib"],"drugPmids":["19589924","19779040","17710227","17339191","17785585","17114651"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"G250E","name":"G250E","refResidues":"G","proteinStart":250,"proteinEnd":250,"variantResidues":"E","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Nilotinib"],"drugPmids":["16775235","19589924","19652056","17785585","23502220"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"G250E","name":"G250E","refResidues":"G","proteinStart":250,"proteinEnd":250,"variantResidues":"E","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Bosutinib"],"drugPmids":["21865346","22371878"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"G250E","name":"G250E","refResidues":"G","proteinStart":250,"proteinEnd":250,"variantResidues":"E","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Nilotinib"],"drugPmids":["16775235","19589924","19652056","17785585","23502220"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F359C","name":"F359C","refResidues":"F","proteinStart":359,"proteinEnd":359,"variantResidues":"C","referenceGenomes":["GRCh38","GRCh37"]},"level":"2","drug":["Bosutinib"],"drugPmids":["15930265","19075254"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"T315A","name":"T315A","refResidues":"T","proteinStart":315,"proteinEnd":315,"variantResidues":"A","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Imatinib"],"drugPmids":["17405907","17189410","11861307"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F359C","name":"F359C","refResidues":"F","proteinStart":359,"proteinEnd":359,"variantResidues":"C","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Nilotinib"],"drugPmids":["16775235","19589924","19652056","17785585","23502220"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F317L","name":"F317L","refResidues":"F","proteinStart":317,"proteinEnd":317,"variantResidues":"L","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Imatinib"],"drugPmids":["19925053","20010464","12623848","17189410","17785585"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F359C","name":"F359C","refResidues":"F","proteinStart":359,"proteinEnd":359,"variantResidues":"C","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Imatinib"],"drugPmids":["17405907","17189410","11861307"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"Y253H","name":"Y253H","refResidues":"Y","proteinStart":253,"proteinEnd":253,"variantResidues":"H","referenceGenomes":["GRCh38","GRCh37"]},"level":"2","drug":["Dasatinib"],"drugPmids":["17496201"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"NA","isGenerallyTruncating":false,"description":"NA"},"alteration":"BCR-ABL1 Fusion","name":"BCR-ABL1 Fusion","refResidues":null,"proteinStart":-1,"proteinEnd":100000,"variantResidues":null,"referenceGenomes":["GRCh38","GRCh37"]},"level":"1","drug":["Imatinib"],"drugPmids":["28095277","11287973","12637609","11287972"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"Y253H","name":"Y253H","refResidues":"Y","proteinStart":253,"proteinEnd":253,"variantResidues":"H","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Nilotinib"],"drugPmids":["16775235","19589924","19652056","17785585","23502220"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F359V","name":"F359V","refResidues":"F","proteinStart":359,"proteinEnd":359,"variantResidues":"V","referenceGenomes":["GRCh38","GRCh37"]},"level":"2","drug":["Bosutinib"],"drugPmids":["15930265","19075254"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"E255V","name":"E255V","refResidues":"E","proteinStart":255,"proteinEnd":255,"variantResidues":"V","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Imatinib"],"drugPmids":["17405907","17189410","11861307"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F359C","name":"F359C","refResidues":"F","proteinStart":359,"proteinEnd":359,"variantResidues":"C","referenceGenomes":["GRCh38","GRCh37"]},"level":"2","drug":["Dasatinib"],"drugPmids":["15930265","19779040","19075254"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"V299L","name":"V299L","refResidues":"V","proteinStart":299,"proteinEnd":299,"variantResidues":"L","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Dasatinib"],"drugPmids":["17496201","17339191","20131302"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"V299L","name":"V299L","refResidues":"V","proteinStart":299,"proteinEnd":299,"variantResidues":"L","referenceGenomes":["GRCh38","GRCh37"]},"level":"2","drug":["Nilotinib"],"drugPmids":["15930265","23086624","19075254"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"V299L","name":"V299L","refResidues":"V","proteinStart":299,"proteinEnd":299,"variantResidues":"L","referenceGenomes":["GRCh38","GRCh37"]},"level":"2","drug":["Nilotinib"],"drugPmids":["15930265","23086624","19075254"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"T315A","name":"T315A","refResidues":"T","proteinStart":315,"proteinEnd":315,"variantResidues":"A","referenceGenomes":["GRCh38","GRCh37"]},"level":"2","drug":["Nilotinib"],"drugPmids":["15930265","23086624","19075254"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":104,"subtype":"Mixed Phenotype Acute Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1","code":"MPALBCRABL1","color":"LightSalmon","mainType":"Leukemia","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"NA","isGenerallyTruncating":false,"description":"NA"},"alteration":"BCR-ABL1 Fusion","name":"BCR-ABL1 Fusion","refResidues":null,"proteinStart":-1,"proteinEnd":100000,"variantResidues":null,"referenceGenomes":["GRCh38","GRCh37"]},"level":"Dx1","drug":[],"drugPmids":["7564526","22015493"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"E255V","name":"E255V","refResidues":"E","proteinStart":255,"proteinEnd":255,"variantResidues":"V","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Nilotinib"],"drugPmids":["16775235","19589924","19652056","17785585","23502220"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"NA","isGenerallyTruncating":false,"description":"NA"},"alteration":"BCR-ABL1 Fusion","name":"BCR-ABL1 Fusion","refResidues":null,"proteinStart":-1,"proteinEnd":100000,"variantResidues":null,"referenceGenomes":["GRCh38","GRCh37"]},"level":"1","drug":["Dasatinib"],"drugPmids":["17496201","20131302","21931113"],"drugAbstracts":[{"link":"http://www.bloodjournal.org/content/130/Suppl_1/98","abstract":"Hunger et al. ASH 2017"}]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"V299L","name":"V299L","refResidues":"V","proteinStart":299,"proteinEnd":299,"variantResidues":"L","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Bosutinib"],"drugPmids":["21865346","22371878"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"G250E","name":"G250E","refResidues":"G","proteinStart":250,"proteinEnd":250,"variantResidues":"E","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Imatinib"],"drugPmids":["17405907","17189410","11861307"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F359C","name":"F359C","refResidues":"F","proteinStart":359,"proteinEnd":359,"variantResidues":"C","referenceGenomes":["GRCh38","GRCh37"]},"level":"2","drug":["Dasatinib"],"drugPmids":["17496201"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"E255V","name":"E255V","refResidues":"E","proteinStart":255,"proteinEnd":255,"variantResidues":"V","referenceGenomes":["GRCh38","GRCh37"]},"level":"2","drug":["Dasatinib"],"drugPmids":["17496201"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"Y253H","name":"Y253H","refResidues":"Y","proteinStart":253,"proteinEnd":253,"variantResidues":"H","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Imatinib"],"drugPmids":["17405907","17189410","11861307"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":95,"subtype":"B-Lymphoblastic Leukemia/Lymphoma","code":"BLL","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":3,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"T315A","name":"T315A","refResidues":"T","proteinStart":315,"proteinEnd":315,"variantResidues":"A","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Dasatinib"],"drugPmids":["17496201","17339191","20131302"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F359V","name":"F359V","refResidues":"F","proteinStart":359,"proteinEnd":359,"variantResidues":"V","referenceGenomes":["GRCh38","GRCh37"]},"level":"2","drug":["Dasatinib"],"drugPmids":["15930265","19779040","19075254"],"drugAbstracts":[]},{"oncogenic":"Likely Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"E255K","name":"E255K","refResidues":"E","proteinStart":255,"proteinEnd":255,"variantResidues":"K","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Imatinib"],"drugPmids":["19925053","20010464","12623848","17189410","17785585"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":351,"subtype":"B-Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2);BCR-ABL1","code":"BLLBCRABL1","color":"LimeGreen","mainType":"B-Lymphoblastic Leukemia/Lymphoma","level":5,"tissue":"Lymphoid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"NA","isGenerallyTruncating":false,"description":"NA"},"alteration":"BCR-ABL1 Fusion","name":"BCR-ABL1 Fusion","refResidues":null,"proteinStart":-1,"proteinEnd":100000,"variantResidues":null,"referenceGenomes":["GRCh38","GRCh37"]},"level":"Dx1","drug":[],"drugPmids":["28665419"],"drugAbstracts":[]},{"oncogenic":"Oncogenic","cancerTypes":[{"id":560,"subtype":"Chronic Myelogenous Leukemia","code":"CML","color":"LightSalmon","mainType":"Myeloproliferative Neoplasms","level":4,"tissue":"Myeloid","tumorForm":"LIQUID"}],"variant":{"gene":{"entrezGeneId":25,"hugoSymbol":"ABL1","oncogene":true,"grch37Isoform":"ENST00000318560","grch37RefSeq":"NM_005157.4","grch38Isoform":"ENST00000318560","grch38RefSeq":"NM_005157.4","geneAliases":["v-abl","bcr/abl","JTK7","BCR-ABL","c-ABL1","c-ABL","ABL","CHDSKM"],"genesets":[],"tsg":false},"consequence":{"term":"missense_variant","isGenerallyTruncating":false,"description":"A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"},"alteration":"F359I","name":"F359I","refResidues":"F","proteinStart":359,"proteinEnd":359,"variantResidues":"I","referenceGenomes":["GRCh38","GRCh37"]},"level":"R1","drug":["Imatinib"],"drugPmids":["19925053","20010464","12623848","17189410","17785585"],"drugAbstracts":[]}]